M&A Deal Summary |
|
|---|---|
| Date | 2025-06-23 |
| Target | dne pharma - Business |
| Sector | Life Science |
| Buyer(s) | Navamedic |
| Sellers(s) | dne pharma |
| Deal Type | Divestiture |
| Deal Value | 225M NOK |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2002 |
| Sector | Life Science |
| Employees | 42 |
| Revenue | 531M NOK (2024) |
Navamedic is a pharmaceutical company, markets, and sells pharmaceuticals and other health care products in Northern European region. The company's product portfolio includes generic, branded, and patented pharmaceuticals, as well as medical devices, food supplements, cosmetics, and other health care products. Navamedic was founded in 2002 and is based in Oslo, Norway.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: Norway M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-05-05 |
Impolin
Täby, Sweden Impolin specializes in products related to the pre and post-treatment of bariatric surgery. Impolin’s portfolio includes Modifast, a range of diet and meal replacement products, and MedMade, a multivitamin and minerals tablet for post-bariatric surgery supplementation, which are products aimed at supporting patients during weight loss or obesity treatment, including bariatric surgery. Impolin is based in Täby, Sweden. |
Buy | kr50M |
dne pharma is a developer and distributor of addiction and pain therapies, including opioid substitution treatments and emergency overdose medications. Its portfolio supports public health efforts across Scandinavia and beyond. dne pharma is headquartered in Oslo, Norway.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: Norway M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
